மெலிசா பிராட்போர்டு க்லக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மெலிசா பிராட்போர்டு க்லக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மெலிசா பிராட்போர்டு க்லக் Today - Breaking & Trending Today

RareStone Inc. Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China

RareStone Inc. Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Melissa Bradford Klug , Shawn Xiang , Pain Challenge Charity Foundation , Duchenne Muscular Dystrophy Mutual Association , Rarestone Inc , Hypercortisolism Alliance , Tencent Holdings Limited , China Mucopolysaccharidosis Typei Patient Alliance , Prnewswire Rarestone Inc , Stone Inc , Citrine Medicine , Beijing Pain Challenge Charity Foundation , Duchenne Muscular Dystrophy Care , Shenzhen Muscular Dystrophy Baby Care , Leukodystrophy Connect , Baby Support , Rarestone Chief Executive Officer , Vice President , Stone Media Contact , Chief Business Officer , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , மெலிசா பிராட்போர்டு க்லக் , ஸ்டோந் இன்க் ,

RareStone Inc. Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China

RareStone Inc. Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Melissa Bradford Klug , Rarestone Inc , Rarestone Group , National Medical Products Association , Prnewswire Rarestone Inc , Stone Inc , Citrine Medicine , New Drug Application , Chief Business Officer , Media Contact , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , மெலிசா பிராட்போர்டு க்லக் , தேசிய மருத்துவ ப்ராடக்ட்ஸ் சங்கம் , ஸ்டோந் இன்க் , சிட்ரின் மருந்து , புதியது மருந்து விண்ணப்பம் , தலைமை வணிக அதிகாரி , மீடியா தொடர்பு ,

Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)

Published: May 12, 2021

CAMBRIDGE, Mass. and SHANGHAI, May 12, 2021 /PRNewswire/ Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has signed a licensing agreement with Diurnal Group plc (AIM: DNL), a specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases. The deal provides Citrine with exclusive rights to develop and commercialize Efmody
® (hydrocortisone modified-release hard capsules – development name Chronocort
®) in the Greater China market. In January, Citrine signed a licensing agreement with Dirunal Group for Alkindi,
® the first preparation of hydrocortisone specifically designed for use in children suffering from pediatric adrenal insufficiency (AI) and congenital adrenal hyperplasia (CAH). ....

United Kingdom , Melissa Bradford Klug , Finsbury Glover Hering , Dandan Dong , Sarah Sutton , Dirunal Group For Alkindi , European Commission For Efmody , European Medicines Agency , Diurnal Group , Dirunal Group , European Commission , Chief Business Officer , Managing Director , Medical Screening , Congenital Adrenal Hyperplasia , Adrenal Insuffiency , United Kingdom Headquartered , ஒன்றுபட்டது கிஂக்டம் , மெலிசா பிராட்போர்டு க்லக் , ஃபின்ஸ்பரி குளோவர் ஹெர்ரிங் , சாரா சுட்டன் , ஐரோப்பிய தரகு , தலைமை வணிக அதிகாரி , நிர்வகித்தல் இயக்குனர் , மருத்துவ திரையிடல் ,

Diurnal (AIM:DNL) | RNS | Diurnal Group PLC - Agreement with Citrine Medicine for Efmody

$1.0 million and will receive
$28.75 million in additional cash payments upon achievement of certain regulatory milestones and sales milestones based on annual sales thresholds. Diurnal will also receive tiered royalties on sales ranging from low to mid double-digits.

Citrine is a therapeutics platform company focused on the
Greater China market that was co-founded by Vivo Capital, F-Prime Capital and Eight Roads Ventures. Citrine is focused on creating a therapeutic platform to deliver rare disease drugs to the Chinese market and to develop the first ever rare disease ecosystem in the country. The Company signed an original licensing agreement with Citrine in ....

United Kingdom , Hong Kong , Melissa Bradford Klug , Foster Mitchell , Emma Earl , Freddy Crossley , Martin Whitaker , Richard Bungay , Alex Davis , Rupert Dearden , Simon Conway , Citrine Medicine Inc , Panmure Gordon United Kingdom Limited Nominated Adviser , Diurnal Group , Citrine Medicine , Vivo Capital , F Prime Capital , Eight Roads , Chief Business Officer , Medical Screening , Chief Executive , Chief Financial , Nominated Adviser , Sole Broker , Investor Relations , Congenital Adrenal Hyperplasia ,

Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)

/PRNewswire/ Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has signed a licensing agreement with Diurnal Group. ....

United Kingdom , Melissa Bradford Klug , Finsbury Glover Hering , Dandan Dong , Sarah Sutton , Dirunal Group For Alkindi , European Commission For Efmody , European Medicines Agency , Diurnal Group , Dirunal Group , European Commission , Chief Business Officer , Managing Director , Medical Screening , Congenital Adrenal Hyperplasia , Adrenal Insuffiency , United Kingdom Headquartered , Citrine Medicine , ஒன்றுபட்டது கிஂக்டம் , மெலிசா பிராட்போர்டு க்லக் , ஃபின்ஸ்பரி குளோவர் ஹெர்ரிங் , சாரா சுட்டன் , ஐரோப்பிய தரகு , தலைமை வணிக அதிகாரி , நிர்வகித்தல் இயக்குனர் , மருத்துவ திரையிடல் ,